HAE FY 2020 Earnings Report — Haemonetics Corporation Revenue & Financial Results | Market Cap Arena

Haemonetics CorporationHAE

FY 2020 Earnings

Reported May 20, 2020

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2020	Prior Q	FY 2019	QoQ Change	YoY Change
Revenue	$988M	—	$968M	—	2.2%
Op. Income	$103M	—	$84M	—	23.7%
Gross Margin	49.4%	—	43.2%	—	6.2pp
Net Margin	7.7%	—	5.7%	—	2.1pp
EPS (Diluted)	$1.48	—	$1.04	—	42.3%
Free Cash Flow	$109M	—	$40M	—	171.5%

Revenue Flow

Item	Amount
REVENUE	$988M
Cost of Revenue	$501M
GROSS PROFIT	$488M
R&D Expenses	$39M
Selling & Marketing	$4M
General & Administrative	$262M
SG&A Expenses	$266M
Other Expenses	$79M
Operating Expenses	$384M
Cost & Expenses	$885M
OPERATING INCOME	$103M
Interest Income	$0
Interest Expense	$16M
Other Income/Expenses	-$16M
INCOME BEFORE TAX	$87M
Income Tax Expense	$11M
Net Income from Continuing Ops	$77M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$77M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$77M
D&A	$92M
EBIT	$166M
EBITDA	$258M
EPS	$2
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$988M
Cost of Revenue	$501M
GROSS PROFIT	$488M
R&D Expenses	$39M
Selling & Marketing	$4M
General & Administrative	$262M
SG&A Expenses	$266M
Other Expenses	$79M
Operating Expenses	$384M
Cost & Expenses	$885M
OPERATING INCOME	$103M
Interest Income	$0
Interest Expense	$16M
Other Income/Expenses	-$16M
INCOME BEFORE TAX	$87M
Income Tax Expense	$11M
Net Income from Continuing Ops	$77M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$77M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$77M
D&A	$92M
EBIT	$166M
EBITDA	$258M
EPS	$2
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$77M
Depreciation & Amortization	$110M
Stock-Based Compensation	$20M
Deferred Income Tax	-$7M
Other Non-Cash Items	$42M
Change in Working Capital	-$85M
OPERATING CASH FLOW	$158M
Capital Expenditure	-$49M
Acquisitions (Net)	-$25M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$17M
NET CASH FROM INVESTING	-$57M
Net Debt Issuance	$32M
Common Stock Repurchased	-$175M
Common Dividends Paid	$0
Other Financing Activities	$12M
NET CASH FROM FINANCING	-$131M
FREE CASH FLOW	$109M
Net Change in Cash	-$32M

Balance Sheet

Item	Amount
Cash & Equivalents	$137M
Short-Term Investments	$0
Net Receivables	$165M
Inventory	$270M
Other Current Assets	$0
TOTAL CURRENT ASSETS	$604M
PP&E (Net)	$253M
Goodwill	$211M
Intangible Assets	$133M
Long-Term Investments	$0
Tax Assets	$4M
Other Non-Current Assets	$62M
TOTAL NON-CURRENT ASSETS	$663M
TOTAL ASSETS	$1.3B
Account Payables	$51M
Short-Term Debt	$77M
Deferred Revenue	$29M
Other Current Liabilities	$45M
TOTAL CURRENT LIABILITIES	$275M
Long-Term Debt	$306M
Deferred Revenue NC	$0
Deferred Tax Liabilities	$14M
Other Non-Current Liabilities	$34M
TOTAL NON-CURRENT LIABILITIES	$405M
TOTAL LIABILITIES	$680M
Common Stock	$503.0K
Additional Paid-In Capital	$553M
Retained Earnings	$79M
Treasury Stock	$0
Accum. Other Comp. Income	-$45M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$587M
Minority Interest	$0
TOTAL EQUITY	$587M
TOTAL LIABILITIES & EQUITY	$1.3B
Total Debt	$442M
Net Debt	$305M